Estimates Revisions Kobayashi Pharmaceutical Co., Ltd. Deutsche Boerse AG
Stocks
KOY
JP3301100008
Personal Products
|
Market Closed -
Deutsche Boerse AG
09:06:00 06/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 38.60 EUR | -1.03% |
|
+2.66% | +34.97% |
| 09-25 | Kobayashi Pharmaceutical Says No Decision Made on Potential Take-Private Deal by NSSK, CVC Capital Partners | MT |
| 09-24 | Kobayashi Reportedly in ¥500 Billion Buyout Talks After Red-Yeast Case | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Kobayashi Pharmaceutical Co., Ltd.(4967)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Kobayashi Pharmaceutical Co., Ltd.(4967)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Kobayashi Pharmaceutical Co., Ltd.(4967)
EBIT
Dividend / Share (DPS)
Data source:
Kobayashi Pharmaceutical Co., Ltd.(4967)
Cash or Net Debt
- Stock Market
- Stocks
- 4967 Stock
- KOY Stock
- Consensus Kobayashi Pharmaceutical Co., Ltd.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
